Change - Announcement of Cessation::Cessation of Singapore Centre Director - Dr Cordelia Chan
Issuer & Securities
ISEC HEALTHCARE LTD.
ISEC HEALTHCARE LTD. - SG1AD9000001 - 40T
Change - Announcement of Cessation
Date &Time of Broadcast
Announcement Sub Title
Cessation of Singapore Centre Director - Dr Cordelia Chan
Submitted By (Co./ Ind. Name)
Description (Please provide a detailed description of the event in the box below)
The resignation of the Singapore Centre Director, Dr Cordelia Chan.
ISEC Healthcare Ltd. (the "Company") was listed on Catalist of the Singapore Exchange Securities Trading Limited (the "SGX-ST") on 28 October 2014. The initial public offering of the Company (the "IPO") was sponsored by PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor" or "PPCF").
This announcement has been prepared by the Company and its contents have been reviewed by the Sponsor for compliance with the SGX-ST Listing Manual Section B: Rules of Catalist. The Sponsor has not verified the contents of this announcement.
This announcement has not been examined or approved by the SGX-ST. The Sponsor and the SGX-ST assume no responsibility for the contents of this announcement, including the accuracy, completeness or correctness of any of the information, statements or opinions made or reports contained in this announcement.
The contact person for the Sponsor is Ms Keng Yeng Pheng, Associate Director, Continuing Sponsorship, at 16 Collyer Quay,#10-00 Income at Raffles, Singapore 049318, telephone (65) 6229 8088.
Name Of Person
Dr Cordelia Chan
Is effective date of cessation known?
If yes, please provide the date
Detailed Reason (s) for cessation
Non concurrence of new remuneration terms.
Based on its enquiries, the Company's sponsor, PrimePartners Corporate Finance Pte Ltd., is satisfied that, other than as disclosed in this announcement, there are no material reasons for the cessation of Dr Cordelia Chan as the Singapore Centre Director of the Company.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
Any other relevant information to be provided to shareholders of the listed issuer?
Date of Appointment to current position
Does the AC have a minimum of 3 members (taking into account this cessation)?
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Singapore Centre Director
Role and responsibilities
Practising medical doctor at Mount Elizabeth Novena Specialist Centre and Medical Director of International Specialist Eye Centre Pte. Ltd., a wholly owned subsidiary of the Company.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Shareholding interest in the listed issuer and its subsidiaries?
5,600,000 ordinary shares
Past (for the last 5 years)